Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 16Active not recruiting 16Completed 4Not yet recruiting 3Withdrawn 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Urologic Diseases 1Radiation Injuries 1Oligometastatic Prostate Cancer 1Neoplasm Recurrence, Local 1Gastrointestinal Diseases 1

Interventions

Specimen Handling 57Magnetic Resonance Spectroscopy 39Carboplatin 32Cyclophosphamide 29Gemcitabine 28Bevacizumab 24pembrolizumab 23Cisplatin 23Biopsy 23Paclitaxel 22Standard of Care 21Radiotherapy 21Drug Therapy 21fludarabine 20Injections 20Capecitabine 20venetoclax 19Oxaliplatin 19Nivolumab 18Interviews as Topic 17toripalimab 16Dexamethasone 16Blood Specimen Collection 16Radiosurgery 14tislelizumab 13cemiplimab 13anlotinib 13Azacitidine 13Pemetrexed 12Irinotecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Androgen Antagonists × 90 days × Clear all
NCT07490210 2026-03-24

OMPC-RPM

Fudan University

Phase 2 Not yet recruiting
300 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT07483658 2026-03-19

HYP-OP-RT

CHU de Quebec-Universite Laval

Phase NA Not yet recruiting
434 enrolled
GastrointestinalGenitourinary

Gastrointestinal Diseases, Neoplasm Recurrence, Local, Prostatic Neoplasms, Radiation Injuries, Urologic Diseases

NCT07476677 2026-03-17

ANDARP

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡